Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

InstantGMP Inc. celebrates four years with Cartesian Therapeutics


News provided by

InstantGMP Inc.

Aug 23, 2022, 00:00 ET

Share this article

Share toX

Share this article

Share toX

InstantGMP™ celebrates four years of proudly supporting  Cartesian Therapeutics’ groundbreaking work in the field of RNA cell therapy
InstantGMP™ celebrates four years of proudly supporting Cartesian Therapeutics’ groundbreaking work in the field of RNA cell therapy
Youtube
Youtube

InstantGMP PRO Software allows the renowned RNA cell therapy company, Cartesian Therapeutics, to move from preclinical development to clinical testing more efficiently and effectively.

CARY, N.C., Aug. 23, 2022  /PRNewswire-PRWeb/ -- InstantGMP™ celebrates four years of proudly supporting Cartesian Therapeutics' groundbreaking work in the field of RNA cell therapy via our -all-in-one manufacturing and quality system, InstantGMP PRO.

Based in Gaithersburg, MD, Cartesian Therapeutics is a pioneer in RNA cell therapy. A new category in disease therapeutics, RNA cell therapy combines the RNA from RNA therapeutics with the immune cell from DNA-based cell therapy. This combination allows cells to both produce and deliver RNA therapeutics to the source of the disease in a safer and more precise method.

InstantGMP PRO allows us to move from preclinical development to clinical trials quickly,” Kalayoglu stated. “Right now we have three assets in clinical development for three different disease categories. Accomplishing these goals quickly was possible thanks to this all-in-one manufacturing system.

Post this

As a fully integrated company, Cartesian Therapeutics performs all of their discovery, manufacturing and quality management in-house. To help them make this possible, Cartesian Therapeutics searched for a Good Manufacturing Practices (GMP) software that could help them improve their processes, increase productivity, and ensure quality and accuracy at every phase.

They chose the industry's only all-in-one GMP software: InstantGMP PRO.

"Since we do everything in-house at Cartesian Therapeutics, we wanted to invest in a GMP software that did everything in one system," said Murat Kalayoglu, MD, PhD, President & Chief Executive Officer of Cartesian Therapeutics. "When we began to research software, we discovered that most products only supported one aspect of GMP manufacturing. There were others that supported multiple needs, but they would still require us to purchase additional platforms to essentially fill in the gaps. When we found InstantGMP PRO, it met all of our needs."

"Having this all-in-one system in place allows us to move from preclinical development to clinical trials quickly," Kalayoglu continued. "Right now, we have three assets in clinical development for three different disease categories. Accomplishing these goals so quickly was possible thanks to InstantGMP PRO software."

As the industry's only all-in-one GMP software solution, InstantGMP PRO provides Cartesian Therapeutics with the following features:

  • Make To Order Batch Records: Simplifies the development and approval processes for Clinical Trials Material manufacturing.
  • Quality Management System (QMS): Allows users to set quality assurance activities, easily document deviations, perform investigations, and better manage raw materials and outgoing finished products.
  • Inventory Management: Permits users to trace, monitor and record every step of the inventory process.
  • Document Management System (DMS): Enables users to store, organize and secure access to all production files.
  • Sandbox: Provides customers with a completely blank copy of the software so they can test, train, develop and experiment in a safe environment without negatively impacting the information in the official database.

As with all of its GMP software solutions, InstantGMP PRO is frequently updated with new features and benefits, and is validated out of the box. These system updates allow customers like Cartesian Therapeutics to improve their processes so they can remain at the forefront of their industry.

For four years, Cartesian Therapeutics has benefited from the enhanced productivity and quality control provided by InstantGMP PRO software. In turn, InstantGMP has enjoyed supporting this pioneering company and their breakthroughs in RNA cell therapeutics for autoimmune, oncologic, and respiratory disorders.

We look forward to continuing our relationship with Cartesian Therapeutics as they continue to revolutionize the RNA cell therapy industry!

To learn more about InstantGMP PRO all-in-one manufacturing and quality software, contact us to schedule a demonstration.

About InstantGMP™, Inc.

Founded by pharmaceutical industry veteran Dr. Richard Soltero, InstantGMP, Inc., offers affordable all-in-one manufacturing and quality software. The company develops cloud-based electronic batch record software and standard operating procedures specific to industries that are required to follow FDA manufacturing regulations and Good Manufacturing Practices ("GMP").

As a manufacturing software company, InstantGMP™ pioneered accessible, easy-to-use electronic batch record software for products manufactured using GMPs. The Company's updated software simplifies the documentation and approval procedures for quality processes that keep all quality documentation organized in an electronic format while providing for quality checks and workflow processes to make compliance with FDA requirements easy.

Media Contact

Jeremy Hall, InstantGMP Inc., 757-659-4500, [email protected]

Robert Pochadt, InstantGMP Inc., 215-275-9660, [email protected]

Twitter, Facebook

SOURCE InstantGMP Inc.

Modal title

InstantGMP PRO Software Informational pamphlet
View PDF
InstantGMP PRO Software Informational pamphlet
InstantGMP PRO Software Informational pamphlet

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.